The retinoblastoma (RB) tumor suppressor protein and the TATA-box-binding protein TimD form contacts with a number of viral transactivator proteins. One of these, the adenovirus EMA protein, can bind to both proteins.
"pocket" domain. The PU.1 sequences required to bind either protein lie within a 75-amino acid region which functions as an independent activation domain in vivo. The ability of PU.1 to contact directly both RB and TFiD through the same 75-residue domain prompted us to look for sequence silarity between these two proteins. We find that the previously defined domain A of the RB pocket shows sequence similarity to the conserved C terminus of TFID, whereas domain B shows sequence similarity to a second general transcription factor, TFHB. The potential for RB to influence transcription by using TFYD-and TFIB-related functions is discussed.
The retinoblastoma (RB) gene is inactivated in a subset of human tumors, and this has led to its classification as a tumor suppressor gene. The mechanisms by which the RB protein brings about its growth control are unknown. However, mounting evidence suggests that RB has a role in the regulation of gene expression. First, it can influence, both positively and negatively, the transcription of certain genes by an RB-responsive element (1, 2) . Second, using the RB "pocket" domain, it can associate with viral transactivating proteins such as the adenovirus ElA protein, simian virus 40 (SV40) large T (tumor) antigen, and papillomavirus E7 protein (for review, see ref. 3 ). Third, it binds to cellular transcription factors such as E2F (4, 5) and c-myc (6) . In the case of E2F, binding to RB correlates with the inhibition of E2F-induced transcription activation (7, 8) . These observations have led to the suggestion that RB controls cell proliferation by binding to and regulating the function of certain transcription factors (9) .
"Basal-level" transcription from RNA polymerase II promoters involves the formation of a multiprotein complex at the TATA box region, which contains RNA polymerase II and a set of "general" transcription factors, such as TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH. "Activated" transcription requires the binding of "regulatory" transcription factors to the promoter. These regulatory factors are thought to mediate activation by forming protein-protein contacts with general transcription factors (32) .
Direct interaction between cellular regulatory and general transcription factors has not yet been established. However, four viral transactivating proteins, the adenovirus ElA (10, 11) , the herpes virus VP16 (12), the Epstein-Barr virus Zta (13) , and the cytomegalovirus IE2 (14) , have been shown to contact directly the TATA box binding protein TFIID and, in the case of VP16, the general factor TFIIB (15) .
Here we show that PU.1, a lymphoid-specific transcription factor with an Ets-like DNA-binding domain (16) , can bind directly to both TFIID and RB. Both of these interactions (PU.1-RB and PU.1-TFIID) are mediated by a 75-amino acid activation domain of PU.1. These results led to sequence comparisons, which show that domains A and B of the RB pocket have sequence similarity to the two general transcription factors TFIID and TFIIB, respectively. The ability ofRB to modulate transcription, using the TFIID and TFIIB similarity regions, is discussed.
MATERIALS AND METHODS
Proteins Produced by in Vitro Translation. Phagemid vectors for PU.1 (pBSPU.1), ElA (pTM1EIA), Spl (pBS-Spl), IE1 (pGEMIEl), and gelsolin were gifts from R. Maki (La Jolla Cancer Research Foundation, La Jolla, CA), A. Berk (University of California, Los Angeles), S. Jackson (Wellcome/CRC Institute, Cambridge, U.K.), B. Rogers (Wellcome, Beckenham, U.K.), and A. Weeds (Medical Research Council Centre, Cambridge, U.K.), respectively. N-terminal deletions of PU.1 were generated by inserting the relevant restriction fragments into the pING14 transcription/ translation vector (S. Ingles, personal communication). The pGPU series oftranslation products was generated by cloning PU.1 in frame with gelsolin and then linearizing at various positions within PU.1. In vitro transcriptions and translations were carried out as previously described (17) .
Glutathione S-Transferase (GST) Fusion Proteins. pGEX-TFIID (168-339) was cloned by inserting an Ssp I-Dra I fragment of the human TFIID gene (encoding residues 168-339) from pKB104 into the Sma I site of pGEX-3X (Pharmacia) in frame with the gene encoding GST. pGEX-TFIID was generated by amplification of DNA encoding amino acids 1-163 of TFIID and subsequent cloning in the BamHI site of pGEX-2T (Pharmacia). The full-length pGEX-TFIID clone was a gift from A. Whitmarsh (Sheffield University), pGEX-RB (379-928) was a gift from W. Kaelin (Harvard Medical School), and pGEX-Vimentin was a gift from N. Torpey (Wellcome/CRC Institute, Cambridge, U.K.). GST fusion protein expression and purification were according to Smith and Johnson (18) as previously described (19) .
"GST-Puli-Down" Assay. Five hundred nanograms of the GST-TFIID fusion proteins on beads was preincubated with bovine serum albumin (final concentration, 1 Nonidet P-40/100 mM NaF/200 1LM sodium orthovanadate/50 mM Tris HCl, pH 8.0). The beads were then washed three times in 1 ml of NETN buffer (100 mM NaCI/1 mM EDTA/0.5% Nonidet P-40/20 mM TrisHCl, pH 8.0), pelleted at 500 x g for 30 s, and boiled in SDS/PAGE sample buffer. Bound proteins were resolved on SDS/polyacrylamide gels. To estimate the proportion of in vitro synthesized protein "pulled down" by the GST fusion, the exact amount of protein added to the binding reaction was always quantified by SDS/PAGE.
Mobility-Shift Analysis. This was carried out as previously described (17) .
32P-Labeling of GST Fusion Proteins. Full-length mouse PU.1 cDNA was cloned in frame with the GST coding sequence in plasmid pGEX 2TK (a generous gift from W. Kaelin and D. Livingstone). The product has a protein kinase A (PKA) phosphorylation site directly adjacent to the C terminus of the thrombin cleavage site. The protein was labeled according to Kaelin et al. (5) .
"Far-Western" Blotting. Proteins were resolved by SDS/ PAGE and blotted onto nitrocellulose in the absence of methanol. Blots were then denatured and renatured and probed with 32P-labeled GST-PU.1 as previously described (5 
RESULTS
ofTFIID and contain the previously identified binding site for ElA (11) . Celular PU.1 Protein Binds TFHD. We set out to establish whether the cellular PU.1 protein (rather than in vitro translation product) was capable of binding to GST-TFIID in our assay. PU.1 is expressed in B-cell lines (e.g., A20) but not in T-cell lines (e.g., EL4) (16) , and accordingly PU.1-specific DNA-binding activity can be detected in A20 cells but not in EL4 cells (Fig. 1B, lanes 1-4) . The GST-TFIID fusion protein was mixed with extracts from either A20 cells or EL4 cells and then precipitated with glutathione-agarose beads. The proteins bound to GST-TFIID were then released by using 0.2% deoxycholate and incubated with an oligonucleotide containing a PU.1 binding site. Fig. 1B shows that GST-TFIID purifies a PU.1-specific DNA-binding activity from In Vitro Synthesized PU.1 Binds to TIID. The observation that viral transcription factors such as ElA, VP16, and IE2 contact TFIID directly prompted us to ask whether the cellular transcription factor PU.1 had the same property. To establish the existence of such protein-protein interaction we used an assay we term the "GST-pull-down." In this assay, in vitro synthesized, radiolabeled PU.1 protein is allowed to interact with a bacterially expressed GST-TFIID fusion protein. The TFIID fusion protein is then precipitated (along with any interacting PU.1 protein) by using glutathioneagarose beads, which bind GST.
Fig . 1A shows the amount of radiolabeled PU.1 protein added to the GST-TFIID fusion (input protein). A number of other radiolabeled proteins were also included in this experiment, to serve as controls. As a positive control we used ElA, a protein previously shown to bind TFIID. As negative controls we used (i) the nonnuclear protein gelsolin (residues 407-755; ref. 20) and (ii) a highly negatively charged transactivator protein from human cytomegalovirus, IE1 (21) , which works in a TATA-box-independent manner (14) . We also included a cellular transcription factor, Spl, which appears to require an "adaptor" protein(s) for TFIIDdependent activation and is therefore likely to bind TFIID indirectly (if at all). Fig. 1A shows that PU.1, like the positive control ElA, can bind to GST-TFIID in a pull-down assay, whereas none of the other proteins, Spl, IE1, or gelsolin-(407-755) can do so. When TFIID N-and C-terminal GST fusion proteins are used (Fig. 1A) it is clear that the PU.1-TFIID interaction requires the highly conserved C-terminal domain of TFIID (residues 168-339, TFIID-C) but not the highly divergent N terminus (residues 1-163, TFIID-N). The ElA protein also binds to the C but not the N terminus of TFIID (Fig. 1A) . We have further mapped the TFIID domain to which PU.1 binds; it is a 70-amino acid sequence (residues 202-272) in the TFIID C terminus (data not shown). These sequences span the region between the two imperfect repeats Biochemistry
, whereas a control GST-vimentin fusion protein does not bind the PUA protein from A20 cells (lane 7). In contrast, the GST-TFIID protein does not purify a protein with Spl-specific DNAbinding activity from A20 cells (Fig. 1B, lane 11 ) even though such activity is present in these cells (lanes 8-10). These results (with cellular proteins) are in agreement with those obtained with in vitro synthesized PU.1 and Spl (Fig. 1A) . They confirm that the PU.1 protein can interact with TFIID whereas Spl cannot. The Activation Domain of PU.1 Binds TFUD. If the interaction between PU.1 and TFIID is biologically significant, we would expect the PU.1 sequences required for TFIID binding to coincide with sequences required for transcriptional activation. To investigate such a correlation we first sought to identify the transcription activation domain(s) of PU.1. For this purpose we fused the PU.1 protein to the DNA-binding domain of the yeast protein GAL4 and analyzed the ability of this fusion protein to activate a GAL4-site-bearing promoter in transient transfection assays (Fig. 2) . The full-length GAL4-PU.1 fusion protein is inactive in this type of assay, since, as reported for many other transcription factors, the PU.1 DNA-binding domain (present at residues 161-272) is likely to interfere with GAL4 DNA binding. Progressive C-terminal truncations reveal that the PU.1 activation domain lies within the N-terminal 75 amino acids of the protein [PU(1-75), Fig. 2] .
We next used radiolabeled N-and C-terminal truncation products of PU.1 in a pull-down assay to map the domain responsible for TFIID binding (Fig. 3A, lanes 1-5) (Fig. 4 A and B ). These results demonstrate that PU.1 can specifically bind to GST-RB-(379-928) proteins. This region of RB contains the "pocket" domain, which has been shown to interact with a number of cellular proteins (22) in addition to ElA and large T antigen. We next asked whether the PU.1 sequences required for RB binding coincide with the PU.1 activation domain. Deletions of the PU.1 protein (analogous to those used to analyze TFIID binding in Fig. 3A) were used to analyze binding to GST-RB-(379-928) in a pull-down assay (Fig. 3B) . The results indicate that the PU.1 activation domain is required for RB binding, since its deletion severely reduces binding (Fig. 3B, lanes 1-5) . The N-terminal 75 residues of PU.1 (which contain the activation domain) are capable of directing RB binding, but sequences between residues 75 and 182 are required for full RB-binding activity (lanes 6-12) . Thus, the PU.1 protein contains sequences within its activation domain that can dictate binding to both TFIID and RB.
PU.1 Binds to TFEID and RB Directly. In the experiments described so far, we cannot exclude the possibility that PU.1-TFIID or PU.1-RB interactions are mediated by a protein present in the rabbit reticulocyte lysate. We therefore carried out a far-Western blot analysis (10) Each of these proteins was incubated with GST-TFIID-(168-339) (GST-TFIID-C in Fig. 1 ) linked to glutathione-agarose beads. After centrifugation of the beads the PU.1 protein coprecipitated with GST-TFIID was resolved on an SDS/1Oo polyacrylamide gel and visualized by autoradiography. In lanes 6-12, PU. 1 deletion proteins fused to gelsolin (G) were radiolabeled with 35S after in vitro translation and subjected to pull-down analysis using GST-TFIID-(168-339). (B) Identification of PU.1 sequences required for binding to RB. Pull-down assays were performed as described for A, except GST-RB (residues 379-928) was used.
GST-Vimentin recognizes GST-RB-(379-928) and GST-TFIID-(168-339) but not GST, indicating that the interactions are direct. DISCUSSION PU.1 Binds RB and TFIID. We present evidence that the regulatory transcription factor PU.1 can directly contact in vitro the general transcription factor TFIID and the tumor suppressor protein RB. These interactions are mediated by the activation domain of PU.1, suggesting that they are relevant to the transcriptional activation functions of this lymphoid-specific factor.
The viral transactivation proteins ElA, T antigen, and E7 contact RB through the highly conserved LXCXE motif. Analysis of the PU.1 sequence has failed to identify such a motif within the binding site for RB. Thus PU.1, E2F (4), and c-myc (6) constitute a class of cellular transcription factors that contact RB in a region that lacks the LXCXE motif but that contains their activation domain.
RB Shows Sequence Similarity to TFIID and TFIIB. Since the PU.1 activation domain contacts both the RB and TFIID proteins directly, we examined whether TFIID and RB share sequence similarity. Computer alignment of the two sequences identified a region in the C terminus of TFIID (residues 256-288) with significant similarity to a region within the RB pocket domain (residues 504-535). The ALIGN program (23) indicates that this similarity is 6.6 standard deviations above that found when randomized sequences of identical length are compared. Closer inspection ofthe TFIID and RB sequences revealed that the similarity is more extensive. As shown in Fig. 5 , it extends over 151 residues of the TMIID C terminus (residues 167-317). Using a very stringent similarity assessment (R/K, E/D, S/T, F/Y, and identical. A striking feature of this homology is that it overlaps almost precisely domain A of the RB pocket (Fig. 6) . It is also worth noting that, like TFIID (24), RB contains an imperfect repeat in this region (residues 399-462 and 505-563) and displays DNA-binding activity (26, 27) .
Since the RB pocket is composed of two subdomains (A and B), both of which are required for the binding of viral transcription factors such as ElA (28, 29) , we argued that the second subdomain (B) may be similar to a region of another general transcription factor. The search for such a correlation revealed extensive similarity between domain B of the RB pocket and the C terminus of TFIIB (25) . This general transcription factor is thought to be involved in transcriptional start site selection and has been shown to bind to TFIID. In the alignment shown in Fig. 5 , RB and TFIIB show 35% similarity and 20% identity over 154 residues of TFIIB (residues 117-270). When this region of TFIIB is used to search the Pir protein data base [using the PROSRCH program (30) at a PAM value of 250] the human and mouse RB proteins are identified as the proteins with the most similarity to TFIIB. This alignment (residues 117-270 of TFIIB and 658-816 of RB) is given a score of 10 standard deviations above the mean by the ALIGN program.
The presence ofboth TFIID-and TFIIB-related sequences within the RB pocket is highly provocative, considering that these two general factors form the preinitiation complex which binds to the TATA box region and recruits RNA polymerase II. It suggests that the RB pocket may mimic a function(s) normally carried out jointly by TFIID and TFIIB. One function performed by both proteins is the binding of the viral transactivator VP16. If TFIID and TFIIB are common targets for regulatory transcription factors, RB may function by binding to and regulating the transcription factors which contact TFIID and/or TFIIB.
Since a large proportion of the TFIID and TFIIB proteins shows sequence similarity to RB, it is conceivable that a number of functions carried out by these two general factors are also carried out by RB. Although little is known about the TFIIB protein, several functions have been assigned to TFIID: (i) it binds DNA (the TATA box); (ii) it contacts the C-terminal heptapeptide repeat domain of RNA polymerase II; (iii) it binds tightly to several associated factors (TAFs); (iv) it forms a complex with other general transcription factors such as TFIIA and TFIIB; and (v) it interacts with proteins that negatively regulate transcription (for review, see ref. 31) . It is unclear at this stage which (if any) of these functions is conserved in RB. However, the presence of sequence similarity between the RB pocket and two general transcription factors is consistent with the observed effects of RB on transcription. How RB uses these sequence similarities to bring about the regulation of transcription remains to be determined.
